Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 17, 2026 04:22PM
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 14, 2025 04:16PM
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. May 15, 2025 04:51PM
Avalo Therapuetics (AVTX) Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants Nov 12, 2024 07:06AM
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants Nov 12, 2024 07:00AM


Aug 23, 2024 04:17PM Form SC 13G Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 29, 2024 04:01PM Avalo Reports 2023 Financial Results and Provides Business Updates
Mar 27, 2024 04:01PM Avalo Therapuetics (AVTX) Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
Mar 27, 2024 04:01PM Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million